| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 14:31 | Amgen To Near $100, Outperforming Pfizer | | 4 | Seeking Alpha |
| 10.02.
| Chart of the Day: Amgen | | 9 | Minyanville |
| 10.02.
| Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight.... | | 64 | BörseGo |
| Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight.
(© BörseGo AG 2012 - Autor: Thomas Gansneder, Redakteur)
Mehr lesen zu:
Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight.... | |
| 10.02.
| Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight. | | 61 | BörseGo |
| Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight.
(© BörseGo AG 2012 - Autor: Thomas Gansneder, Redakteur)
Mehr lesen zu:
Morgan Stanley startet BE Aerospace, AVEO Pharma und Amgen mit Equalweight. | |
| 10.02.
| XETR DIVIDEND INFORMATION - 13.02.2012 - 1 | | 87 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 10.02.2012 CUM DIVIDENDE UND AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.02.2012. THE EX-DIVIDEND DAY WILL BE 13.02.2012....
Mehr lesen zu:
XETR DIVIDEND INFORMATION - 13.02.2012 - 1 | |
| 10.02.
| XFRA DIVIDEND INFORMATION - 13.02.2012 - 2 | | 128 | Xetra Newsboard |
| FOLGENDE WERTPAPIERE WERDEN AM 10.02.2012 CUM DIVIDENDE UND AM 13.02.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 10.02.2012. THE EX-DIVIDEND DAY WILL BE 13.02.2012....
Mehr lesen zu:
XFRA DIVIDEND INFORMATION - 13.02.2012 - 2 | |
| 09.02.
| How to Tell if Amgen Is Hiding Weakness | | 6 | Motley Fool |
| 09.02.
| Watch for Shares of Amgen to Approach Support at $66.95 | | 1 | SmarTrend |
| 09.02.
| Analysts' Actions: CSCO, MMM, CIT, AMGN | | 3 | The Street |
| 09.02.
| Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings | | 84 | PR Newswire |
| CHICAGO, Feb. 9, 2012 /PRNewswire/ -- Zacks Equity Research highlights Amgen, Inc. (Nasdaq: AMGN) as the Bull of the Day and Montpelier Re Holdings (NYSE: MRH) as the Bear of the Day. In...
Mehr lesen zu:
Zacks Bull and Bear of the Day Highlights: Amgen, Montpelier Re Holdings, Cisco Systems, Illumina and Roche Holdings | |
| 09.02.
| Downgrade Alert for Amgen | | 3 | SmarTrend |
| 08.02.
| Amgen Upped to Outperform | | 11 | Zacks |
| 08.02.
| Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer Drug | | 7 | Bloomberg |
| 08.02.
| Amgen (AMGN) fails to win panel backing for expanded Xgeva cancer use -Bloomberg | | 4 | StreetInsider.com |
| 08.02.
| Amgen Bearish Moving Average Crossover Alert | | 1 | SmarTrend |
| 08.02.
| The Secret Reason Amgen's Earnings Are Awesome | | 6 | Motley Fool |
| 08.02.
| Patrick Dempsey and Beverly Hills Police Motor Officers Lead Top U.S. Cyclists Up Rodeo Drive to Appear at Press Event in Anticipation of the World-Famous Drive Playing a Part in the 2012 Amgen Tour of California Road Race in May | | 7 | PR Newswire |
| BEVERLY HILLS, Calif., Feb. 8, 2012 /PRNewswire/ --
WHAT:
Three world-class cyclists, Amgen Tour of California (confirmed) participants and likely U.S. Olympic Team Members, along with...
Mehr lesen zu:
Patrick Dempsey and Beverly Hills Police Motor Officers Lead Top U.S. Cyclists Up Rodeo Drive to Appear at Press Event in Anticipation of the World-Famous Drive Playing a Part in the 2012 Amgen Tour of California Road Race in May | |
| 08.02.
| Amgen (AMGN) to Discuss XGEVA sBLA w/ U.S. FDA ODAC | | - | StreetInsider.com |
| 08.02.
| Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting | | 9 | PR Newswire |
| THOUSAND OAKS, Calif., Feb. 8, 2012 /PRNewswire/ --Amgen (NASDAQ: AMGN) will discuss the data from the supplemental Biologics License Application (sBLA) for XGEVA® (denosumab) to treat...
Mehr lesen zu:
Amgen to Discuss Application for New Use of XGEVA® (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting | |
| 08.02.
| Can Amgen Convince Docs to Recommend Approval? | | 6 | Motley Fool |
